Alzheimer's, Dementia & Parkinson's Disease Risk Reduction

This meta-analysis is the cleanest aggregate estimate for Parkinson disease incidence. Across prospective studies, higher total physical activity was associated with lower PD risk, with a stronger signal for moderate-to-vigorous activity.

The moderate-to-vigorous estimate is the most relevant to an aerobic exercise program because it captures activity intense enough to stress and improve the cardiovascular system.

The study also reported dose-response evidence in men: each additional 10 MET-hours/week of moderate-to-vigorous activity was associated with lower PD risk.

This study directly strengthens the Parkinson disease evidence base in women, where older pooled data had been less definitive.

The analysis used repeated physical-activity measurements across long follow-up, rather than relying only on a single baseline measure.

The key clinical message is straightforward: women with higher long-term activity had substantially lower incident PD than women in the lowest activity group.

NIH-AARP provides one of the largest single-cohort signals linking moderate-to-vigorous activity with lower future Parkinson disease occurrence.

The most relevant finding is intensity-specific: the protective association was seen for moderate-to-vigorous activity in midlife and later adulthood.

Participants with consistent and frequent moderate-to-vigorous activity across the relevant periods had approximately 40% lower PD risk than participants who were consistently inactive.

This meta-analysis is directly relevant because the endpoint is incident Alzheimer's disease rather than a broader dementia composite.

The intensity gradient is especially useful for Phalanx: moderate physical activity was associated with lower AD risk, while high physical activity showed the largest association.

The pooled estimate across more than two million participants makes this one of the most important supportive sources for the AD risk-reduction claim.

Iso-Markku et al. is useful because it synthesizes a large body of prospective evidence rather than relying on one cohort.

The AD-specific estimate supports lower Alzheimer's disease incidence among more physically active participants.

The all-cause dementia estimate is directionally similar and slightly stronger, reinforcing the broader neurodegenerative prevention signal.

This study is not a questionnaire-based physical-activity estimate; it uses measured exercise capacity from standardized treadmill testing.

The association was graded across fitness categories, with the highest-fit veterans showing the lowest incident ADRD risk.

Because high-intensity aerobic training is one of the most efficient ways to improve cardiorespiratory fitness, this study is highly relevant to an aerobic risk-reduction program.

This study is highly aligned with the Phalanx aerobic-exercise argument because the exposure is device-measured moderate-to-vigorous activity, not broad self-reported lifestyle activity.

The risk gradient is large: each higher MVPA category had a lower dementia hazard than the inactive reference group.

The >=140 minute/week group provides the most compelling headline estimate, with HR 0.31 versus participants reporting 0 MVPA minutes/week.

Brellenthin et al. asks a key Phalanx question: does intensity add signal beyond total MVPA volume?

The answer was supportive. Participants who included vigorous activity within their MVPA had lower dementia incidence than participants reporting no vigorous activity.

The strongest association appeared in the group whose MVPA included some, but not mostly, vigorous activity.

This is a useful newer accelerometer analysis because it tests both dose and weekly pattern.

Participants accumulating >=300 minutes/week of MVPA had lower dementia incidence whether the activity was concentrated into 1-2 days or distributed more regularly.

For Phalanx, the key point is that a sustained weekly MVPA dose showed a supportive association with lower all-cause dementia risk.

Petermann-Rocha et al. is important because it uses objective accelerometry and reports a clear dose-response across MVPA categories.

The all-cause dementia gradient is large, with progressively lower risk as MVPA rises from below-guideline levels to higher guideline-achieving levels.

The study also reported lower Alzheimer's disease risk among participants achieving at least 600 MET-minutes/week of MVPA, making it supportive of both the dementia and AD claims.

This study is useful because it translates activity into a patient-friendly metric: steps and cadence.

Total step volume was associated with lower dementia incidence, while purposeful steps and peak cadence showed even stronger associations.

The cadence finding is especially relevant to aerobic training because brisk, sustained stepping is a practical real-world marker of higher-intensity activity.

This study adds a fitness-specific signal to the dementia evidence base, using a stationary-bike test rather than broad self-report.

High cardiorespiratory fitness was associated with substantially lower all-cause dementia incidence.

The finding among participants with moderate or high genetic risk is especially useful clinically because it supports aerobic fitness as relevant even in higher-risk populations.